FOUNDAYO Trademark
FOUNDAYO is a USPTO trademark filed by Eli Lilly and Company. Status: Pending.
Prosecution Summary
Trademark Summary
FOUNDAYO is the word mark for pharmaceutical preparations, including treatment-related products for conditions such as alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, and many other listed conditions. The application is currently in a “Notice of Allowance (NOA) sent” stage, and the applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date. The owner/applicant is Eli Lilly and Company. No active opposition or other legal proceedings are listed.
Recent Activity
The application was filed on August 8, 2025, and it was published for
Trademark Facts
| Mark | FOUNDAYO |
|---|---|
| Serial Number | 99327654 |
| Status | Pending |
| Filing Date | 2025-08-08 |
| Mark Type | Combined |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Eli Lilly and Company |
| Attorney of Record | Bruce W. Longbottom |
| Prosecution Events | 10 |
| Latest Event | NOAM on 2026-03-17 |
Goods & Services
Class 005: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alopecia, Alzheimer’s disease, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Coronavirus disease, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, fibromyalgia, gastrointestinal diseases and disorders, headaches, hearing loss, heart failure, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, lupus, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, osteoarthritis, pain, Parkinson’s disease, peripheral arterial disease, Psoriasis, Psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, vascular diseases